The signaling pathways in obesity‐related complications
Journal of Cell Communication and Signaling · 2024-06 · 18 (2)
DOI: 10.1002/ccs3.12039 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cell Communication and Signaling, online erschienen am 07.06.2024. Verfasst von Preethi Chandrasekaran und 1 weiteren Autor:innen. Beteiligte Einrichtung: UT Southwestern Medical Center Dallas Dallas Texas USA. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Deutsche Krebshilfe, Medizinische Fakultät, RWTH Aachen University.
Abstract (Originalsprache)
Obesity, a rapidly expanding epidemic worldwide, is known to exacerbate many medical conditions, making it a significant factor in multiple diseases and their associated complications. This threatening epidemic is linked to various harmful conditions such as type 2 diabetes mellitus, hypertension, metabolic dysfunction‐associated steatotic liver disease, polycystic ovary syndrome, cardiovascular diseases (CVDs), dyslipidemia, and cancer. The rise in urbanization and sedentary lifestyles creates an environment that fosters obesity, leading to both psychosocial and medical complications. To identify individuals at risk and ensure timely treatment, it is crucial to have a better understanding of the pathophysiology of obesity and its comorbidities. This comprehensive review highlights the relationship between obesity and obesity‐associated complications, including type 2 diabetes, hypertension, (CVDs), dyslipidemia, polycystic ovary syndrome, metabolic dysfunction‐associated steatotic liver disease, gastrointestinal complications, and obstructive sleep apnea. It also explores the potential mechanisms underlying these associations. A thorough analysis of the interplay between obesity and its associated complications is vital in developing effective therapeutic strategies to combat the exponential increase in global obesity rates and mitigate the deadly consequences of this polygenic condition.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- UT Southwestern Medical Center Dallas Dallas Texas USA.
- Institute of Molecular Pathobiochemistry Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC) RWTH University Hospital Aachen Aachen Germany.
ORCID-Profile: Preethi Chandrasekaran, Ralf Weiskirchen
Förderung
- Deutsche Forschungsgemeinschaft
- Deutsche Krebshilfe
- Medizinische Fakultät, RWTH Aachen University
Zitieren
APA
Chandrasekaran, P., & Weiskirchen, R. (2024). The signaling pathways in obesity‐related complications. Journal of Cell Communication and Signaling, 18(2). https://doi.org/10.1002/ccs3.12039
Vancouver
Chandrasekaran P, Weiskirchen R. The signaling pathways in obesity‐related complications. Journal of Cell Communication and Signaling. 2024;18(2). doi:10.1002/ccs3.12039
BibTeX
@article{Chandrasekaran2024,
author = {Chandrasekaran, Preethi and Weiskirchen, Ralf},
title = {The signaling pathways in obesity‐related complications},
journal = {Journal of Cell Communication and Signaling},
year = {2024},
volume = {18},
number = {2},
doi = {10.1002/ccs3.12039}
}
EUVIMED